JP2015529327A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529327A5
JP2015529327A5 JP2015528457A JP2015528457A JP2015529327A5 JP 2015529327 A5 JP2015529327 A5 JP 2015529327A5 JP 2015528457 A JP2015528457 A JP 2015528457A JP 2015528457 A JP2015528457 A JP 2015528457A JP 2015529327 A5 JP2015529327 A5 JP 2015529327A5
Authority
JP
Japan
Prior art keywords
ratio
positive correlation
correlation
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528457A
Other languages
English (en)
Japanese (ja)
Other versions
JP6153613B2 (ja
JP2015529327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/031812 external-priority patent/WO2014031164A1/en
Publication of JP2015529327A publication Critical patent/JP2015529327A/ja
Publication of JP2015529327A5 publication Critical patent/JP2015529327A5/ja
Application granted granted Critical
Publication of JP6153613B2 publication Critical patent/JP6153613B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528457A 2012-08-23 2013-03-15 乳がん治療を決定する方法 Expired - Fee Related JP6153613B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261692331P 2012-08-23 2012-08-23
US61/692,331 2012-08-23
PCT/US2013/031812 WO2014031164A1 (en) 2012-08-23 2013-03-15 Method for determining breast cancer treatment

Publications (3)

Publication Number Publication Date
JP2015529327A JP2015529327A (ja) 2015-10-05
JP2015529327A5 true JP2015529327A5 (enExample) 2016-01-28
JP6153613B2 JP6153613B2 (ja) 2017-06-28

Family

ID=50150282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528457A Expired - Fee Related JP6153613B2 (ja) 2012-08-23 2013-03-15 乳がん治療を決定する方法

Country Status (7)

Country Link
US (2) US10175240B2 (enExample)
EP (1) EP2888594B1 (enExample)
JP (1) JP6153613B2 (enExample)
AU (1) AU2013306380A1 (enExample)
CA (1) CA2882621A1 (enExample)
ES (1) ES2696202T3 (enExample)
WO (1) WO2014031164A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6158180B2 (ja) 2011-07-29 2017-07-05 メディベイション プロステイト セラピューティクス， インコーポレイテッド 乳がんの処置
US10175240B2 (en) 2012-08-23 2019-01-08 The Regents Of The University Of Colorado, A Body Corporate Method for determining breast cancer treatment
RU2017120330A (ru) 2014-12-12 2019-01-14 Медивэйшн Простейт Терапьютикс, Ллс Способ прогнозирования ответа на терапевтические агенты для лечения рака молочной железы и способ лечения рака молочной железы
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
MX2021001857A (es) * 2018-08-17 2021-10-13 Genentech Inc Star Metodos de diagnostico y terapeuticos para el tratamiento del cancer de mama.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008185A (en) 1985-11-04 1991-04-16 Cell Analysis Systems, Inc. Methods and apparatus for the quantitation of nuclear proteins
US5292638A (en) * 1990-12-07 1994-03-08 The Regents Of The University Of California Method of determining functional estrogen receptors for prognosis of cancer
JP2004509072A (ja) 2000-06-28 2004-03-25 ブリストル−マイヤーズ　スクイブ　カンパニー 選択的アンドロゲン受容体モジュレーター並びにその同定、設計及び使用方法
JP5078100B2 (ja) * 2006-04-18 2012-11-21 ウェルスタット バイオロジクス コーポレイション 循環癌細胞におけるステロイド受容体の検出および処置
JP2010500577A (ja) * 2006-08-07 2010-01-07 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 癌の予後および予測シグナチャーのプロテオミクスパターン
EP2065474A1 (en) * 2007-11-28 2009-06-03 Siemens Healthcare Diagnostics GmbH A method to assess prognosis and to predict therapeutic response to endocrine treatment
WO2009137543A2 (en) * 2008-05-06 2009-11-12 Ore Pharmaceuticals Inc. Methods for breast cancer screening and treatment
US10175240B2 (en) 2012-08-23 2019-01-08 The Regents Of The University Of Colorado, A Body Corporate Method for determining breast cancer treatment

Similar Documents

Publication Publication Date Title
NO2025022I1 (no) Belzutifan, or a pharmaceutically acceptable salt thereof, particularly belzutifan.
WO2015082046A3 (de) Substituierte oxepine
JP2013188229A5 (enExample)
KR102087056B9 (ko) 금속판, 금속판의 제조 방법, 및 금속판을 사용해서 증착 마스크를 제조하는 방법
JP2015503422A5 (enExample)
JP2012030068A5 (enExample)
JP2016037652A5 (enExample)
JP2015186128A5 (enExample)
JP2016540360A5 (ja) 基板処理システム及び基板処理方法
EP2971213A4 (en) IMPROVED ALUMINUM MAGNESIUM LITHIUM ALLOYS AND METHOD FOR THE PRODUCTION THEREOF
JP2013140343A5 (enExample)
JP2016508934A5 (enExample)
HUE055176T2 (hu) Mikrobiális olaj, eljárás mikrobiális olaj elõállítására, töményített mikrobiális olaj és eljárás töményített mikrobiális olaj elõállítására
LT3038656T (lt) Glikozaminoglikano junginys, jo gamybos būdas ir panaudojimas
EP3073171A4 (en) Heat-insulation film, and heat-insulation-film structure
JP2014513003A5 (enExample)
IL242437B (en) Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process
SG11201510003VA (en) Anti-fibrogenic compounds, methods and uses thereof
JP2015521279A5 (enExample)
GB2512869B (en) A composite having acoustic properties, manufacturing the composite, a component comprising a composite, manufacturing the component and uses thereof
JP2017077228A5 (ja) 移動式搾乳装置および該移動式搾乳装置を使用した放牧方法
PT2980096T (pt) Métodos de preparação de 2,3,5 tri-hidroxi-androst-6-ona e utilização do mesmo
ES1078895Y (es) Mantel enrollable.
JP2015009865A5 (enExample)
JP2014519290A5 (enExample)